Rates of genetic consultation in high-grade serous ovarian cancer patients in the era of PARP inhibitor therapy: A population-based study.

Shannon E Brent Jacob McGee Danielle VicusRaymond KimAndrea F Eisen Andrew S Wilton Lilian T Gien

Published in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2024)

Between 2012 and 2019, genetic consultation rates improved significantly among HGSC patients; however, a large proportion of patients never attended consultation. Further exploration of barriers to care is warranted to improve consultation rates and ensure equitable access to care.

Keyphrases

palliative care
high grade
newly diagnosed
ejection fraction
healthcare
dna damage
mesenchymal stem cells
patient reported outcomes
pain management
health insurance
affordable care act